Intravesical instillation therapy with adriamycin for bladder cancer in the Korean study group.
Eighteen cases of bladder cancer were treated with intravesical instillation therapy with 60 mg Adriamycin daily. Overall, the treatment was markedly effective in two cases, effective in nine cases, and ineffective in seven cases. Bladder irritation was noted in four cases. Postinstillation therapy was required in most cases.
D000328:Adult; D000368:Aged; D002291:Carcinoma, Papillary / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003556:Cystitis / Q000139:chemically induced; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007723:Korea; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D004317:Doxorubicin